Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDiploma Regulatory News (DPLM)

Share Price Information for Diploma (DPLM)

Share Price is delayed by 15 minutes
Get Live Data
7,125.00    -5.00 (-0.07%)
Bid:
7,125.00
Ask:
7,130.00
Spread: 5.00 (0.07%)
Market Cap: £9.55b
DPLM Live PriceLast checked at - London Stock Exchange

Intraday Diploma Share Chart

Acquisition

10 Sep 2010 07:00

RNS Number : 4595S
Diploma PLC
10 September 2010
Β 

ο»Ώ

Β 

DIPLOMAΒ PLC

12 CHARTERHOUSE SQUARE, LONDON EC1M 6AX

TELEPHONE: +44 (0)20 7549 5700

FACSIMILE: +44 (0)20 7549 5715

Β 

FOR IMMEDIATE RELEASE

Β 

10 September 2010

Β 

Β 

DIPLOMA PLC

Β 

DIPLOMA ACQUIRES AN OEM SEALS BUSINESS IN THE UNITED STATES ANDΒ A HEALTHCARE BUSINESS IN AUSTRALIA

Β 

Β 

Diploma PLC, the international group of businesses supplying specialised technical products and services, is pleased to announce the acquisition of 100% of All Seals Inc ("All Seals") for a maximum consideration of Β£7.8m (US$11.9m), before expenses. On 30 July 2010, Diploma PLC also completed the acquisition of 80% of Big Green Surgical Company Pty Limited ("BGS") for a maximum consideration of Β£1.4m (A$2.4m), before expenses.

Β 

All Seals Inc

Β 

All Seals is a well established supplier of O rings and custom moulded seals to Industrial OEM customers across a range of specialist applications in aerospace, medical, agriculture and general manufacturing industries. All Seals employs 22 staff and operates from a leased facility in Santa Ana, California in the United States.

Β 

All Seals will join the Hercules Fluid Power Group ("HFPG"), Diploma's North American Seals Group, alongside HFPG's other OEM seal business, RT Dygert. All Seals and RT Dygert will be complementary businesses within HFPG as All Seals sells ca. 75% of its product in California and the South Western states of the US, while RT Dygert is concentrated in the Mid-West.

Β 

At the time of acquisition, All Seals was owned by Mr J Barnett who will remain as an Executive until 31 December 2010, and thereafter be available as a consultant to the business.

Β 

Unaudited revenues of All Seals in the year ended 31 December 2009, when industrial markets were particularly weak, were US$7.8m (Β£5.1m). In the first eight months of 2010, revenues have rebounded strongly and are ca. 30% ahead of the prior comparable period.

Β 

The initial cash consideration for All Seals will be US$10.5m (Β£6.9m), which will be met from the Group's existing cash resources. This may be subject to minor adjustment based on the net assets at completion. Further deferred consideration up to an aggregate maximum of US$1.4m (Β£0.9m) may be payable in 2011, depending primarily on the operating profit out-turn of the business in the year ending 31 December 2010.

Β 

Big Green Surgical Company Pty Limited

Β 

BGS is a specialised distributor of electrosurgery consumables and equipment supplied to both public and private hospitals in Australia and New Zealand. The business is a smaller, more narrowly focused version of the Group's existing AMT Electrosurgery business in Canada and shares a number of common suppliers. BGS employs 6 staff and operates from a small leased facility in Newcastle, close to Sydney in New South Wales, Australia.

Β 

At the time of acquisition, BGS was jointly owned by Mr & Mrs A Bennett and Mr Bennett will remain in place as Managing Director following the acquisition for a minimum period of three years. BGS will report directly into the management team of Diploma's Canadian Healthcare businesses.

Β 

In the year ended 30 June 2010, BGS reported unaudited revenues of A$3.4m (Β£2.0m). The initial consideration paid for 80% of the share capital was A$2.4m (Β£1.4m). The outstanding 20% of shares will be retained by the Managing Director for three years and be subject to put/call options, based on an agreed multiple of operating profit.

Β 

The Board expects both acquisitions to be immediately earnings enhancing for the Group.

Β 

Bruce Thompson, Chief Executive of Diploma PLC said:

Β 

"The acquisition of All Seals is an important addition to our developing OEM Seals business in North America. The BGS acquisition, although relatively small, is strategically important in opening up new geographic opportunities for our established Healthcare business."

Β 

Β 

Β 

Β 

For further enquiries please contact:

Bruce Thompson, Chief Executive Officer

020 7549 5700

Nigel Lingwood, Group Finance Director

020 7549 5705

Simon Bloomfield, Bankside Consultants

020 7367 8861

Β 

Β 

Β 

Β 

NOTE TO EDITORS:

Β 

Diploma PLC is an international group of businesses supplying specialised technical products and services to the Life Sciences, Seals and Controls industries.

Β 

Diploma achieves stable growth and attractive margins from its focus on supplying specialised technical products to markets which value high levels of customer service, technical support and value adding activities. A high proportion of revenues are generated from essential products and services funded by operating, rather than capital budgets.

Β 

The Group employs ca. 825 employees and its principal operating businesses are located in the UK, Germany, US and Canada.

Β 

Over the last five years, the Group has grown adjusted earnings per share at an average of ca. 16% p.a. through a combination of organic growth and acquisitions. The current market capitalisation is ca. Β£290m.

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
ACQKKCDBABKDKCK
Date   Source Headline
22nd Nov 20217:00 amRNSFinal Results
18th Nov 20217:00 amRNSISSUE OF SHARES AND TOTAL VOTING RIGHTS
20th Oct 20217:00 amRNSAppointment of Chairman Designate
13th Oct 20219:10 amRNSHolding(s) in Company
22nd Jul 20217:00 amRNSDirectorate Change
22nd Jul 20217:00 amRNSTrading Statement
21st May 20217:00 amRNSDirectorate Change
17th May 20217:00 amRNSDividend Declaration
17th May 20217:00 amRNSHalf-year Report
30th Apr 20219:48 amRNSHolding(s) in Company
24th Mar 20217:00 amRNSTrading Statement
12th Mar 20216:32 pmRNSHolding(s) in Company
18th Feb 20216:13 pmRNSHolding(s) in Company
10th Feb 20214:50 pmRNSHolding(s) in Company
20th Jan 20212:45 pmRNSResult of AGM
20th Jan 20217:00 amRNSTrading Statement
13th Jan 20217:00 amRNSAppointment of Senior Independent Director
7th Jan 20217:00 amRNSArrangements for the AGM in light of COVID-19
23rd Dec 202010:29 amRNSHolding(s) in Company
22nd Dec 202011:14 amRNSHolding(s) in Company
21st Dec 20207:00 amRNSDirector/PDMR Shareholding
18th Dec 20209:54 amRNSHolding(s) in Company
7th Dec 20207:00 amRNSANNUAL REPORT & ACCOUNTS 2020 AND NOTICE OF AGM
24th Nov 20207:00 amRNSDirector/PDMR Grant of LTIP Award
17th Nov 202010:08 amRNSDividend Declaration
16th Nov 20207:00 amRNSFinal Results
30th Oct 20202:18 pmRNSHolding(s) in Company
23rd Oct 20209:47 amRNSHolding(s) in Company
19th Oct 20207:00 amRNSACQUISITION OF WINDY CITY WIRE
1st Oct 20207:00 amRNSTotal Voting Rights
30th Sep 202010:51 amRNSHolding(s) in Company
25th Sep 20203:46 pmRNSHolding(s) in Company
25th Sep 20202:36 pmRNSHolding(s) in Company
23rd Sep 20207:00 amRNSResult of Placing
22nd Sep 20206:02 pmRNSRetail Offer via PrimaryBid.com - Replacement
22nd Sep 20205:54 pmRNSProposed placing New Ordinary Shares - Replacement
22nd Sep 20205:44 pmRNSAcquisition of Windy City Wire - Replacement
22nd Sep 20204:38 pmRNSRetail Offer via PrimaryBid.com
22nd Sep 20204:38 pmRNSProposed placing of New Ordinary Shares
22nd Sep 20204:34 pmRNSAcquisition of Windy City Wire
27th Aug 20207:00 amRNSTrading Statement
23rd Jun 20207:00 amRNSDirectorate Change
11th May 20207:00 amRNSHalf-year Report
6th May 20207:00 amRNSChange of Company Secretary
7th Apr 20207:05 amRNSDirector Declaration
25th Mar 20207:00 amRNSTrading Statement
17th Mar 20203:15 pmRNSHolding(s) in Company
10th Mar 20203:29 pmRNSDirector/PDMR Shareholding
6th Feb 20207:00 amRNSDirectorate Change
17th Jan 20203:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.